Last updated: 18 July 2019 at 5:06pm EST

Kenneth L Holt Net Worth




The estimated Net Worth of Kenneth L Holt is at least $782 millier dollars as of 16 March 2017. Kenneth Holt owns over 6,000 units of Rockwell Medical Inc stock worth over $51,783 and over the last 21 years Kenneth sold RMTI stock worth over $730,079.

Kenneth Holt RMTI stock SEC Form 4 insiders trading

Kenneth has made over 32 trades of the Rockwell Medical Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently Kenneth sold 6,000 units of RMTI stock worth $35,880 on 16 March 2017.

The largest trade Kenneth's ever made was exercising 35,000 units of Rockwell Medical Inc stock on 8 February 2013 worth over $116,900. On average, Kenneth trades about 6,958 units every 83 days since 2003. As of 16 March 2017 Kenneth still owns at least 12,630 units of Rockwell Medical Inc stock.

You can see the complete history of Kenneth Holt stock trades at the bottom of the page.



What's Kenneth Holt's mailing address?

Kenneth's mailing address filed with the SEC is 8217 VICTORIA LAKE DRIVE, , WAXHAW, NC, 28173.

Insiders trading at Rockwell Medical Inc

Over the last 21 years, insiders at Rockwell Medical Inc have traded over $3,082,721 worth of Rockwell Medical Inc stock and bought 689,891 units worth $3,959,861 . The most active insiders traders include Robert L Chioini, David S.Rbi Private Investm... et Thomas E Klema. On average, Rockwell Medical Inc executives and independent directors trade stock every 45 days with the average trade being worth of $170,433. The most recent stock trade was executed by David S.Rbi Private Investm... on 21 December 2020, trading 42,450 units of RMTI stock currently worth $43,724.



What does Rockwell Medical Inc do?

rockwell medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (esrd) and chronic kidney disease (ckd) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. rockwell’s new innovative therapy triferic is the only fda approved drug indicated to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia. via dialysate during each dialysis treatment, triferic replaces the 5-7 mg iron loss that occurs in all patients, maintaining their iron balance. unlike iv iron products, triferic binds iron immediately and completely to transferrin (carrier of iron in the body) upon entering the blood and is then transported directly to the bone marrow to be incorporated into hemoglobin, with no increase in ferritin (stored iron and inflammation) and no anaphylaxis, addressing a significant unmet need in overcoming functional iron deficiency (fid) in esrd patients. visit www



What does Rockwell Medical Inc's logo look like?

Rockwell Medical Inc logo

Complete history of Kenneth Holt stock trades at Rockwell Medical Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
16 Mar 2017 Kenneth L Holt
Directeur
Vente 6,000 $5.98 $35,880
16 Mar 2017
12,630
9 Nov 2016 Kenneth L Holt
Directeur
Vente 19,725 $5.16 $101,781
9 Nov 2016
18,630
9 Nov 2016 Kenneth L Holt
Directeur
Vente 19,725 $5.16 $101,781
9 Nov 2016
18,630
1 Nov 2016 Kenneth L Holt
Directeur
Vente 1,400 $5.92 $8,288
1 Nov 2016
38,355
1 Nov 2016 Kenneth L Holt
Directeur
Vente 1,400 $5.92 $8,288
1 Nov 2016
38,355
19 Oct 2016 Kenneth L Holt
Directeur
Vente 2,533 $6.04 $15,299
19 Oct 2016
39,755
19 Oct 2016 Kenneth L Holt
Directeur
Vente 2,533 $6.04 $15,299
19 Oct 2016
39,755
16 Sep 2016 Kenneth L Holt
Directeur
Vente 8,075 $6.81 $54,991
16 Sep 2016
42,288
16 Sep 2016 Kenneth L Holt
Directeur
Vente 8,075 $6.81 $54,991
16 Sep 2016
42,288
12 Aug 2016 Kenneth L Holt
Directeur
Vente 3,692 $7.31 $26,989
12 Aug 2016
59,883
12 Aug 2016 Kenneth L Holt
Directeur
Vente 3,692 $7.31 $26,989
12 Aug 2016
59,883
9 Feb 2016 Kenneth L Holt
Directeur
Vente 9,520 $6.37 $60,642
9 Feb 2016
50,363
9 Feb 2016 Kenneth L Holt
Directeur
Vente 9,520 $6.37 $60,642
9 Feb 2016
50,363
15 Jan 2016 Kenneth L Holt
Directeur
Exercice d'option 25,000 $3.09 $77,250
15 Jan 2016
63,575
11 Nov 2015 Kenneth L Holt
Directeur
Exercice d'option 25,000 $4.55 $113,750
11 Nov 2015
38,575
12 Sep 2013 Kenneth L Holt
Directeur
Exercice d'option 25,000 $4.55 $113,750
12 Sep 2013
46,509
16 Jul 2013 Kenneth L Holt
Directeur
Vente 7,934 $8.85 $70,216
16 Jul 2013
13,575
8 Feb 2013 Kenneth L Holt
Directeur
Exercice d'option 35,000 $3.34 $116,900
8 Feb 2013
28,914
12 Nov 2012 Kenneth L Holt
Directeur
Vente 2,750 $6.24 $17,160
12 Nov 2012
7,900
8 Nov 2012 Kenneth L Holt
Directeur
Vente 1,549 $6.29 $9,743
8 Nov 2012
10,650
28 Sep 2011 Kenneth L Holt
Directeur
Vente 801 $8.56 $6,857
28 Sep 2011
12,199
22 Sep 2011 Kenneth L Holt
Directeur
Exercice d'option 25,000 $2.79 $69,750
22 Sep 2011
38,000
9 Sep 2010 Kenneth L Holt
Directeur
Vente 4,900 $6.15 $30,135
9 Sep 2010
13,000
3 Sep 2010 Kenneth L Holt
Directeur
Vente 4,100 $5.88 $24,108
3 Sep 2010
17,900
1 Sep 2010 Kenneth L Holt
Directeur
Exercice d'option 15,000 $1.81 $27,150
1 Sep 2010
28,000
27 Aug 2010 Kenneth L Holt
Directeur
Exercice d'option 5,000 $1.81 $9,050
27 Aug 2010
18,000
24 Aug 2010 Kenneth L Holt
Directeur
Exercice d'option 5,000 $1.81 $9,050
24 Aug 2010
18,000
12 Jun 2009 Kenneth L Holt
Directeur
Exercice d'option 24,563 $1.37 $33,651
12 Jun 2009
37,563
10 Jun 2009 Kenneth L Holt
Directeur
Exercice d'option 5,700 $1.88 $10,716
10 Jun 2009
18,700
23 Dec 2008 Kenneth L Holt
Directeur
Exercice d'option 9,737 $0.67 $6,524
23 Dec 2008
22,737
15 Dec 2008 Kenneth L Holt
Directeur
Exercice d'option 10,000 $0.55 $5,500
15 Dec 2008
23,000
26 Jan 2006 Kenneth L Holt
Directeur
Exercice d'option 13,000 $3.90 $50,700
26 Jan 2006
13,000


Rockwell Medical Inc executives and stock owners

Rockwell Medical Inc executives and other stock owners filed with the SEC include: